|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
396,340,000 |
Market
Cap: |
234.16(B) |
Last
Volume: |
872,985 |
Avg
Vol: |
1,557,818 |
52
Week Range: |
$431.41 - $599.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 108 |
Guru Rank Value : 8.2 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile Thermo Fisher Scientific is engaged in serving science. Co.'s segments include: Life Sciences Solutions, which provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, which provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field; and Specialty Diagnostics, which provides diagnostic test kits, reagents, culture media, instruments and associated products for customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
4 |
4 |
Total Buy Value |
$0 |
$0 |
$2,105 |
$2,105 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
148,270 |
178,547 |
273,847 |
585,711 |
Total Sell Value |
$86,651,471 |
$103,537,843 |
$153,017,946 |
$325,380,325 |
Total People Sold |
5 |
6 |
7 |
8 |
Total Sell Transactions |
13 |
17 |
28 |
63 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lynch Thomas J |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
11,657 |
|
- |
|
Mullen James C |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
1,728 |
|
- |
|
Sperling Scott M |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
75,701 |
|
- |
|
Manzi Jim P |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
18,324 |
|
- |
|
Chai Nelson |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
13,148 |
|
- |
|
Keith R. Alexandra |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
438 |
|
- |
|
Harris C Martin |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
7,368 |
|
- |
|
Weisler Dion J |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
3,561 |
|
- |
|
Holmes Joseph R. |
VP & Chief Accounting Officer |
|
2021-05-12 |
4 |
D |
$454.78 |
$1,364 |
D/D |
(3) |
842 |
|
- |
|
Lagarde Michel |
Executive Vice President |
|
2021-05-10 |
4 |
S |
$463.24 |
$10,033,518 |
D/D |
(21,600) |
18,461 |
|
-29% |
|
Lagarde Michel |
Executive Vice President |
|
2021-05-10 |
4 |
OE |
$190.59 |
$4,116,744 |
D/D |
21,600 |
40,061 |
|
- |
|
Lagarde Michel |
Executive Vice President |
|
2021-05-07 |
4 |
S |
$468.71 |
$16,147,636 |
D/D |
(34,168) |
18,461 |
|
-20% |
|
Lagarde Michel |
Executive Vice President |
|
2021-05-07 |
4 |
OE |
$190.59 |
$5,546,169 |
D/D |
29,100 |
52,629 |
|
- |
|
Lagarde Michel |
Executive Vice President |
|
2021-03-07 |
4 |
D |
$446.87 |
$422,292 |
D/D |
(945) |
23,529 |
|
- |
|
Lagarde Michel |
Executive Vice President |
|
2021-03-05 |
4 |
D |
$446.87 |
$44,687 |
D/D |
(100) |
24,474 |
|
- |
|
Williamson Stephen |
Sr. VP and CFO |
|
2021-02-26 |
4 |
D |
$450.08 |
$582,404 |
D/D |
(1,294) |
42,162 |
|
- |
|
Lagarde Michel |
Executive Vice President |
|
2021-02-26 |
4 |
D |
$450.08 |
$256,546 |
D/D |
(570) |
24,574 |
|
- |
|
Jafry Syed A. |
Sr. Vice President |
|
2021-02-26 |
4 |
D |
$450.08 |
$512,641 |
D/D |
(1,139) |
22,349 |
|
- |
|
Hornstra Peter E |
VP & Chief Accounting Officer |
|
2021-02-26 |
4 |
D |
$450.08 |
$31,056 |
D/D |
(69) |
1,962 |
|
- |
|
Stevenson Mark |
Executive Vice President & COO |
|
2021-02-26 |
4 |
D |
$450.08 |
$1,013,130 |
D/D |
(2,251) |
62,302 |
|
- |
|
Boxer Michael A |
Sr. VP and Gen. Counsel |
|
2021-02-26 |
4 |
D |
$450.08 |
$115,671 |
D/D |
(257) |
11,719 |
|
- |
|
Casper Marc N |
Chairman & CEO |
|
2021-02-26 |
4 |
D |
$450.08 |
$2,212,593 |
D/D |
(4,916) |
229,385 |
|
- |
|
Casper Marc N |
Chairman & CEO |
|
2021-02-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,000 |
2,000 |
|
- |
|
Casper Marc N |
Chairman & CEO |
|
2021-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
234,301 |
|
- |
|
Williamson Stephen |
Sr. VP and CFO |
|
2021-02-25 |
4 |
D |
$451.47 |
$506,098 |
D/D |
(1,121) |
43,456 |
|
- |
|
1116 Records found
|
|
Page 14 of 45 |
|
|